Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Immunotargets and Therapy|March 27, 2020
Role of Chemokines and Chemokine Receptors in Rheumatoid ArthritisNoha Mousaad Elemam, Suad Hannawi, Azzam A MaghazachiCurrent Medical Research and Opinion|March 23, 2021
COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remediesNoha Mousaad Elemam, Azzam A Maghazachi, Suad HannawiToxins|December 14, 2017
Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic MoleculesNoha Mousaad Elemam, Suad Hannawi, Azzam A MaghazachiComputational and Structural Biotechnology Journal|February 9, 2021
Chemokines and chemokine receptors during COVID-19 infectionBariaa A Khalil, Noha Mousaad Elemam, Azzam A MaghazachiInternational Journal of Molecular Sciences|June 2, 2021
Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus PatientsNoha Mousaad Elemam, Hind Hasswan, Hayat Aljaibeji, et al.Frontiers in Immunology|February 17, 2022
Complement System: An Immunotherapy Target in Colorectal CancerIman M Talaat, Noha Mousaad Elemam, Maha Saber-AyadViruses|November 11, 2022
CXCL10 Chemokine: A Critical Player in RNA and DNA Viral InfectionsNoha Mousaad Elemam, Iman Mamdouh Talaat, Azzam A MaghazachiJournal of Inflammation Research|October 16, 2020
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune EncephalomyelitisSarah Dhaiban, Mena Al-Ani, Noha Mousaad Elemam, et al.Infection and Drug Resistance|October 16, 2020
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?Mena Al-Ani, Noha Mousaad Elemam, Jennifer Elisabeth Hundt, et al.Genes|May 6, 2020
Differentially Expressed Genes of Natural Killer Cells Can Distinguish Rheumatoid Arthritis Patients from Healthy ControlsNoha Mousaad Elemam, Mahmood Yaseen Hachim, Suad Hannawi, et al.Pageof 4